DECEMBER - 202219TOP 10TOP 10 IN VITRO DIAGNOSTIC SOLUTIONS PROVIDERS - 2022GenMark Diagnostics, Inc. genmarkdx.comGenMark Diagnostics, Inc. is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology.MultiplexDX International multiplexdx.comMultiplexDX International is a provider of diagnostics kits intended to eliminate cancer misdiagnosis by launching accurate, quantitative, and accessible diagnostic tests. The company's services combine the approach of molecular biology and histopathological methods for the treatment of tumours and cancer, enabling oncology patients to go back to their normal life and ensure proper diagnosis by offering highly specialized custom oligonucleotides to the research community.Ortho Clinical Diagnostics orthoclinicaldiagnostics.comOrtho Clinical Diagnostics offers in vitro diagnostics solutions and services. It provides diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. The company operates through three geographic segments such as Americas, EMEA, Greater China, and other Americas segment generates most of the revenue for the firm.Surmodics, Inc. surmodics.comSurmodics, Inc. is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit and the Vitro diagnostics unit. Surmodics derives most of its revenue from the Vitro diagnostics segment.DiaSorin diasorin.comDiaSorin is a global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years their group has been developing, producing and commercializing diagnostic tests, supporting clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized.Todos Medical Ltd. todosmedical.comTodos Medical Ltd. is an in vitro diagnostics company focused on the development of novel blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's Disease, and the distribution of comprehensive solutions for COVID-19 screening. The company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system.
< Page 9 | Page 11 >